Stay updated on Pegcetacoplan in C3 Glomerulopathy: Clinical Trial

Sign up to get notified when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Non-immunoglobulin-mediated membranoproliferative glomerulonephritis as a term and linked the Genetic and Rare Diseases Information Center as a resource. Removed a government funding status notice and the older revision note (v3.4.1).
    Difference
    0.3%
    Check dated 2026-02-11T09:28:25.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Inclusion criteria were updated to require stable doses of medications affecting proteinuria for at least 12 weeks prior to baseline, replacing the previous 812-week requirement. A government funding notice was added to the page, along with a revision entry indicating v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T05:56:01.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The update adds a Show glossary option and a new revision note (Revision: v3.4.0). The changes also include capitalization tweaks in labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'.
    Difference
    0.1%
    Check dated 2026-01-28T04:05:29.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now shown on the page, replacing Revision: v3.3.3. This appears to be a routine site version update and does not modify the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-01-14T01:37:38.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The Locations section was updated to add new study sites across the United States, Australia, Canada, Japan, and Brazil and to remove several previously listed sites.
    Difference
    1%
    Check dated 2025-12-23T17:13:26.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    A new Publications section was added showing the NEJM 2025 article on pegcetacoplan in C3G/IC-MPGN and a PubMed auto-fill note.
    Difference
    0.1%
    Check dated 2025-12-09T01:22:22.000Z thumbnail image

Stay in the know with updates to Pegcetacoplan in C3 Glomerulopathy: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.